Correlation Between Viracta Therapeutics and Sage Therapeutic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viracta Therapeutics and Sage Therapeutic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viracta Therapeutics and Sage Therapeutic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viracta Therapeutics and Sage Therapeutic, you can compare the effects of market volatilities on Viracta Therapeutics and Sage Therapeutic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viracta Therapeutics with a short position of Sage Therapeutic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viracta Therapeutics and Sage Therapeutic.

Diversification Opportunities for Viracta Therapeutics and Sage Therapeutic

0.85
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Viracta and Sage is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Viracta Therapeutics and Sage Therapeutic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sage Therapeutic and Viracta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viracta Therapeutics are associated (or correlated) with Sage Therapeutic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sage Therapeutic has no effect on the direction of Viracta Therapeutics i.e., Viracta Therapeutics and Sage Therapeutic go up and down completely randomly.

Pair Corralation between Viracta Therapeutics and Sage Therapeutic

Given the investment horizon of 90 days Viracta Therapeutics is expected to under-perform the Sage Therapeutic. In addition to that, Viracta Therapeutics is 1.35 times more volatile than Sage Therapeutic. It trades about -0.05 of its total potential returns per unit of risk. Sage Therapeutic is currently generating about -0.06 per unit of volatility. If you would invest  4,133  in Sage Therapeutic on September 4, 2024 and sell it today you would lose (3,554) from holding Sage Therapeutic or give up 85.99% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Viracta Therapeutics  vs.  Sage Therapeutic

 Performance 
       Timeline  
Viracta Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Viracta Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Sage Therapeutic 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sage Therapeutic has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Viracta Therapeutics and Sage Therapeutic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viracta Therapeutics and Sage Therapeutic

The main advantage of trading using opposite Viracta Therapeutics and Sage Therapeutic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viracta Therapeutics position performs unexpectedly, Sage Therapeutic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sage Therapeutic will offset losses from the drop in Sage Therapeutic's long position.
The idea behind Viracta Therapeutics and Sage Therapeutic pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.